Sergio Waxman, MD, MBA

Review

Hemostasis in the Era of the Chronic Anticoagulated Patient

08/01/2008

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Mechanisms for Hemostasis and Comparative Efficacy The technology to produce poly-N-acetylglucosamine (pGlcNAc) polymer is based on a biomaterial that is derived in a fiber form from aseptic cultures of a marine microalgae diatom. Once...

Mechanisms for Hemostasis and...

08/01/2008

Journal of Invasive Cardiology

Rapid Communication

Single-Center Experience with the TandemHeart Percutaneous<br />
Ventricular Assist Device to Support Patients undergoing<br />
High-Risk

08/01/2008

Wael F. Al-Husami , MD;

Frederick Yturralde , MD;

Guru Mohanty , MD;

Christopher Pastore , MD;

Kapildeo Lotun , MD;

David Venesy , MD;

Sergio Waxman , MD, MBA;

Christopher Pyne , MD;

Thomas C. Piemonte , MD;

Richard W. Nesto , MD;

David E. Gossman , MD;

Percutaneous coronary intervention (PCI) offers an alternative form of therapy for patients considered to be at high risk for coronary artery bypass graft surgery (CABG). PCI is associated with substantial morbidity and mortality in the...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Adverse Events After Left Atrial Appendage Closure: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Database

07/26/2020

Mayal Sandhu , MD;

Ritu Chakrabarti , MD;

Rameez Rao , MD;

Alexis K. Okoh , MD;

Rajiv Tayal , MD, MPH;

Najam Wasty , MD;

Sergio Waxman , MD, MBA;

Joseph Heaton , MD;

Christoph Sossou , MD;

Swaiman Singh , MD;

Left atrial appendage (LAA) closure devices are alternative treatments recently approved for patients with atrial fibrillation. Due to the novelty of these devices, limited postapproval surveillance data on LAA closure devices have been...

Left atrial appendage (LAA)...

07/26/2020

Journal of Invasive Cardiology